MYnd Analytics Inc Share Price Nasdaq
Equities
US62857N2027
Biotechnology & Medical Research
Sales 2021 | 20.61M 1.72B | Sales 2022 | 18.39M 1.53B | Capitalization | 12.9M 1.08B |
---|---|---|---|---|---|
Net income 2021 | -15M -1.25B | Net income 2022 | -10M -834M | EV / Sales 2021 | 4.97 x |
Net Debt 2021 | 20.13M 1.68B | Net Debt 2022 | 28.8M 2.4B | EV / Sales 2022 | 2.27 x |
P/E ratio 2021 |
-5.16
x | P/E ratio 2022 |
-1.21
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 48.23% |
Managers | Title | Age | Since |
---|---|---|---|
George Sekulich
PSD | President | 59 | 01/19/01 |
Willis Lee
CHM | Chairman | 64 | 17/19/17 |
Yasushi Nagasaki
DFI | Director of Finance/CFO | 57 | 01/11/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Peu Zen
BRD | Director/Board Member | 71 | 17/19/17 |
Willis Lee
CHM | Chairman | 64 | 17/19/17 |
Ian Zwicker
BRD | Director/Board Member | 77 | 17/19/17 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.07% | 12.09B | |
+0.17% | 11.88B | |
-1.24% | 11.8B |